Brain tumour patients N = 180 (%) | Controls N = 90 (%) | p value | |
---|---|---|---|
Age in years, M (SD) | 56.8 (13.5) | 53.6 (19.5) | 0.16 |
16–59 | 93 (52) | 53 (59) | 0.028 |
60–79 | 84 (46) | 31 (34) | |
≥ 80 | 3 (2) | 6 (7) | |
Gender (N, %) | |||
Male | 86 (48) | 31 (34) | 0.037 |
Female | 94 (52) | 59 (66) | |
Social deprivation index (N, %) | |||
1 | 28 (15.7) | 11 (12.2) | 0.8 |
2 | 43 (24.2) | 26 (28.9) | |
3 | 32 (18.0) | 15 (16.7) | |
4 | 35 (19.7) | 15 (16.7) | |
5 | 40 (22.5) | 23 (25.6) | |
Karnofsky Performance Status median (range) | 90 (50–100) | N.A | N.A |
Tumour histology, N (%) | N.A | N.A | |
High grade glioma (WHO III-IV) | 77 (42.8) | ||
Cerebral metastasis | 28 (15.6) | ||
Meningioma | 42 (23.3) | ||
Low grade glioma (WHO I-II) | 14 (7.8) | ||
CNS Lymphoma | 5 (2.8) | ||
Other | 14 (7.8) | ||
Tumour lobe, N (%) | N.A | N.A | |
Frontal | 68 (37.8) | ||
Temporal | 34 (18.9) | ||
Parietal | 18 (10) | ||
Occipital | 13 (7.2) | ||
Cerebellar | 16 (8.9) | ||
Multiple | 15 (5.4) | ||
Other | 16 (8.9) | ||
Tumour laterality, N (%) | N.A | N.A | |
Left | 80 (44.4) | ||
Right | 64 (35.6) | ||
Bilateral | 22 (12.2) | ||
Midline | 14 (7.8) | ||
Maximum size T1 (axial), mean (mm) (SD) | 41.1 (15.1) | N.A | N.A |
Midline shift, N (%) | N.A | N.A | |
< 5 mm | 119 (66.1) | ||
5–10 mm | 31 (17.2) | ||
> 10 mm | 21 (11.7) | ||
Unknown | 9 (5) |